Tuberous Sclerosis Complex (TSC) and sporadic Lymphangioleiomyomatosis (LAM) are tumor suppressor syndromes sharing the same primary genetic and biochemical features; inactivation of the tumor suppressors TSC1 or TSC2, and aberrant regulation of the PI3K/mTOR pathway. Here, TSC2 is linked to lymphangioleiomyomatosis.